Siemens Takes Next Step in Integrated Dx Plan with Bayer Buy; Will GE Healthcare, Philips Follow? | GenomeWeb

In the latest step in its ongoing strategy to provide integrated in vivo and in vitro diagnostic offerings, Siemens announced last week that it would acquire Bayer Diagnostics for €4.2 billion ($5.26 billion).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.